VERMILION ENERGY INC (VET.CA) Forecast, Price Target & Analyst Ratings
TSX:VET • CA9237251058
16.2 CAD
+0.41 (+2.6%)
Last: Mar 12, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VERMILION ENERGY INC (VET.CA).
Forecast Snapshot
Consensus Price Target
CA$14.84
-8.42% Downside
Next Earnings Forecast
Release DateN/A
PeriodQ1 / 2026
EPS EstimateCA$0.33
Revenue Estimate517.42M
ChartMill Buy Consensus
70.67%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$14.84
Upside
-8.42%
From current price of CA$16.20 to mean target of CA$14.84, Based on 15 analyst forecasts
Low
CA$12.12
Median
CA$14.28
High
CA$19.43
Price Target Revisions
1 Month
2.56%
3 Months
7.74%
Price Target Summary
15 Wall Street analysts provided a forecast for the next 12 months for VET.CA. The average price target is 14.84 CAD. This implies a price decrease of -8.42% is expected in the next year compared to the current price of 16.2.
The average price target has been revised upward by 7.74% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
70.67%
VET.CA was analyzed by 15 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about VET.CA.
In the previous month the buy percentage consensus was at a similar level.
VET.CA was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2022-12-15 | STA Research | Maintains | Hold |
| 2022-12-14 | RBC Royalbank | Upgrade | |
| 2022-12-13 | BMO Financial | Downgrade | |
| 2022-12-05 | JP Morgan & Company | Downgrade | |
| 2022-11-16 | JP Morgan & Company | Downgrade | |
| 2022-11-11 | Stifel FirstEnergy | Downgrade | |
| 2022-11-11 | Raymond James Capital | Downgrade | Outperform |
| 2022-11-11 | Stifel Nicolaus Research | Downgrade | |
| 2022-11-11 | RBC Royalbank | Downgrade | Sector Perform |
| 2022-11-10 | STA Rseearch | Maintains | Hold |
| 2022-11-10 | BMO Financial | Downgrade | Market Perform |
| 2022-11-10 | TD Research | Downgrade | Buy |
| 2022-11-10 | CIBC Capital Markets | Maintains | Neutral |
| 2022-11-10 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-10-18 | STA Research | Maintains | Hold |
| 2022-10-05 | JP Morgan & Company | Downgrade | Hold |
| 2022-09-30 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-09-30 | STA Research | Maintains | Hold |
| 2022-09-15 | JP Morgan & Company | Upgrade | Hold |
| 2022-09-09 | Scotiabank Capital | Upgrade | Outperform |
| 2022-09-09 | STA Research | Maintains | Hold |
| 2022-08-22 | JP Morgan & Company | Upgrade | Underperform |
| 2022-08-22 | CIBC Capital Markets | Upgrade | Neutral |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ1 / 2026
EPS EstimateCA$0.33
Revenue Estimate517.42M
Revenue Q2Q-3.44%
EPS Q2Q233.30%
Number of Analysts2
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.81%
EPS (1 Month)
0.00%
EPS (3 Months)
-60.47%
Next Earnings Summary
The next earnings revenue estimate has been revised downward by 0.81% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.415B 67.35% | 2.008B -41.21% | 1.896B -5.56% | 2.005B 5.73% | 1.959B -2.29% | 1.958B -0.05% | 2.123B 8.43% | 2.027B -4.52% | N/A | |
| EBITDA YoY % growth | 2.453B 90.64% | 1.027B -58.16% | 919.536M -10.42% | 1.14B 23.98% | 1.066B -6.49% | 1.083B 1.59% | 1.264B 16.71% | N/A | N/A | |
| EBIT YoY % growth | 1.876B 162.33% | 313.926M -83.27% | 236.296M -24.73% | 486.82M 106.02% | 356.53M -26.76% | 473.69M 32.86% | 578.42M 22.11% | 486.05M -15.97% | 489.02M 0.61% | |
| Operating Margin | 54.94% | 15.63% | 12.46% | 24.28% | 18.20% | 24.19% | 27.25% | 23.98% | N/A | |
| EPS YoY % growth | 7.80 10.80% | -2.77 -135.51% | -0.30 89.17% | -1.16 -76.85% | 0.45 185.03% | 0.87 92.54% | N/A | N/A | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.33 233.30% | 0.16 110.70% | 0.10 405.00% | 0.29 -65.92% |
| Revenue Q2Q % growth | 517.42M -3.44% | 493.18M 11.32% | 470.66M 7.67% | 518.53M 15.51% |
| EBITDA Q2Q % growth | 276.74M 1.24% | 246.44M -38.71% | 234.32M -58.59% | 273.71M 5.59% |
| EBIT Q2Q % growth | 102.01M 5.22% | 69.589M 67.65% | 71.003M 126.68% | 68.983M -19.17% |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
1.92%
Revenue Next 5 Year
0.27%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
15.06%
EBIT Next 5 Year
15.47%
VERMILION ENERGY INC / VET.CA Forecast FAQ
Can you provide the average price target for VERMILION ENERGY INC stock?
15 analysts have analysed VET.CA and the average price target is 14.84 CAD. This implies a price decrease of -8.42% is expected in the next year compared to the current price of 16.2.
Can you provide the consensus estimates for VERMILION ENERGY INC next earnings?
The consensus EPS estimate for the next earnings of VERMILION ENERGY INC (VET.CA) is 0.33 CAD and the consensus revenue estimate is 517.42M CAD.
What is the number of analysts for VET stock?
The number of analysts covering VERMILION ENERGY INC (VET.CA) is 15.